144 related articles for article (PubMed ID: 38453817)
1. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38453817
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
[TBL] [Abstract][Full Text] [Related]
3. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer.
Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y
Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.
Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.
Zhu XD; Zhang LX; Luo PQ; Zhu H; Wei ZJ; Xu AM
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12191-12201. PubMed ID: 37430160
[TBL] [Abstract][Full Text] [Related]
7. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.
Zhu J; Hao J; Ma Q; Shi T; Wang S; Yan J; Chen R; Xu D; Jiang Y; Zhang J; Li J
Front Oncol; 2021; 11():661040. PubMed ID: 33937076
[TBL] [Abstract][Full Text] [Related]
9. Prognostic prediction model of colorectal cancer based on preoperative serum tumor markers.
Diao YH; Rao SQ; Shu XP; Cheng Y; Tan C; Wang LJ; Peng D
World J Gastrointest Surg; 2024 May; 16(5):1344-1353. PubMed ID: 38817280
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
Front Oncol; 2021; 11():741309. PubMed ID: 34692522
[TBL] [Abstract][Full Text] [Related]
11. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
13. A nomogram was developed using clinicopathological features to predict postoperative liver metastasis in patients with colorectal cancer.
Dou X; Xi J; Zheng G; Ren G; Tian Y; Dan H; Xie Z; Niu L; Duan L; Li R; Wu H; Feng F; Zheng J
J Cancer Res Clin Oncol; 2023 Nov; 149(15):14045-14056. PubMed ID: 37548773
[TBL] [Abstract][Full Text] [Related]
14. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
15. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
[TBL] [Abstract][Full Text] [Related]
16. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
18. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
19. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine M; More A; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine F; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally C; Kee B; Kopetz S; Goldstein D; Uppal A; White MG; Helmink B; Fournier K; Raghav K; Taggart M; Overman MJ; Shen JP
medRxiv; 2023 Sep; ():. PubMed ID: 37745596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]